Increased Risk for Cervical Disease Progression of French Women Infected with the Human Papillomavirus Type 16 E6-350G Variant

To test the significance of human papillomavirus (HPV) type 16 and HPV16 E6 variants as risk factors for viral persistence and progression to high-grade lesion, we did a nested case-control study within a cohort study of >15,000 Caucasian French women. Three groups infected with high-risk HPV were compared: (a) women with cleared infection (controls, n = 201), (b) women with persistent infection (cases, n = 87), and (c) women who progressed into high-grade lesion (cases, n = 58). Women with persistent HPV infection and those that progressed into high-grade lesions were likelier to harbor HPV16 than other high-risk HPV types [odds ratio (OR), 2.4; 95% confidence interval (95% CI), 1.3-4.3 and OR, 4.2; 95% CI, 2.2-8.1, respectively]. Notably, especially elevated ORs of persistence (3.0; 95% CI, 1.4-6.7) and progression (6.2; 95% CI, 2.7-14.3) were found among women who harbored the HPV16 350G variant. Thus, HPV type and HPV16 variant seem to be risk factors for viral persistence and progression of infections into high-grade cervical lesions. Cancer Epidemiol Biomarkers Prev 2006:15(4);820–2

[1]  H. Bernard,et al.  Genome variation of human papillomavirus types: Phylogenetic and medical implications , 2006, International journal of cancer.

[2]  G. Chandy,et al.  HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. , 2005, Cancer letters.

[3]  C. Wheeler,et al.  Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. , 2005, Journal of the National Cancer Institute.

[4]  David R. Scott,et al.  The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.

[5]  R. DeSalle,et al.  The carcinogenicity of human papillomavirus types reflects viral evolution. , 2005, Virology.

[6]  R. DeSalle,et al.  Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses , 2005, Journal of Virology.

[7]  Andrew Glass,et al.  Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci , 2005 .

[8]  J. Baseman,et al.  The epidemiology of human papillomavirus infections. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  C. Wheeler,et al.  Loss of heterozygosity on chromosome 6 in HPV‐16 positive cervical carcinomas carrying the DRB1*1501‐DQB1*0602 haplotype , 2004, Genes, chromosomes & cancer.

[10]  E. Androphy,et al.  Human Papillomavirus Type 16 E6 Amino Acid 83 Variants Enhance E6-Mediated MAPK Signaling and Differentially Regulate Tumorigenesis by Notch Signaling and Oncogenic Ras , 2004, Journal of Virology.

[11]  M. Hagensee,et al.  Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. , 2004, The Journal of general virology.

[12]  A. García-Carrancá,et al.  Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  N. Park,et al.  Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women , 2004, International Journal of Gynecologic Cancer.

[14]  S. Franceschi,et al.  Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis , 2003, British Journal of Cancer.

[15]  M. Tommasino,et al.  Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. , 2003, Human immunology.

[16]  A. Teyssié,et al.  Human papillomavirus type‐16 variants in Quechua aboriginals from Argentina , 2003, Journal of medical virology.

[17]  K. Vaeteewoottacharn,et al.  Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. , 2003, Anticancer research.

[18]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[19]  B. Pollock,et al.  Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. , 2002, Gynecologic oncology.

[20]  P. Chan,et al.  Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. , 2002, The Journal of infectious diseases.

[21]  H. Hausen Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[22]  J. Palefsky,et al.  Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. , 2002, The Journal of infectious diseases.

[23]  N. Kiviat,et al.  Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  G. Voglino,et al.  Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes , 2001, International journal of cancer.

[25]  L. Banks,et al.  The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.

[26]  J. Salmerón,et al.  Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. , 2001, Journal of the National Cancer Institute.

[27]  C. Clavel,et al.  Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women , 2001, British Journal of Cancer.

[28]  T. Rohan,et al.  Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. , 2000, The Journal of general virology.

[29]  G. Voglino,et al.  Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms , 1998, The Lancet.

[30]  E. Wilander,et al.  Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. , 1998, Cancer research.

[31]  K. Holmes,et al.  Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.

[32]  C. Wheeler,et al.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.

[33]  H. Stöppler,et al.  Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation , 1996, Journal of virology.

[34]  E. Franco,et al.  Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.

[35]  H. Gaylord,et al.  AMERICAN ASSOCIATION FOR CANCER RESEARCH. , 1913, California state journal of medicine.